Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Madison Vaccines
505 South Rosa Road, Suite 201
Madison, WI 53719
Phone: 608-467-5269

The principal mission of Madison, Wisconsin-based MVI is the development of therapeutic plasmid DNA vaccine products for patients with prostate cancer. MVI is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines. MVI has licensed patented technologies from WARF, which were developed in the laboratory of Dr. Douglas McNeel at the University of Wisconsin-Madison.

Key Contact
Name
Richard Lesniewski
Title
President
Funding Events

Date
Amount
Type
Investors
Valuation
01/13/14 $8,000,000 Series A State of Wisconsin Investment Board
Venture Investors
Venture Management
Wisconsin Alumni Research Foundation (WARF)
undisclosed